Search Results

You are looking at 1 - 10 of 281 items for :

  • Anatomy and Physiology x
Clear All
Open access

Horaţiu-Cristian Popescu-Vâlceanu, Matei Bratu, Dan Matei Stancu, Maria Antonescu, Dianna Paula Tudor, Raluca Nan, Ramona Maria Drăguţ, Emilia Rusu, Mihaela Posea and Gabriela Radulian

://www.prb.org/pdf13/2013-population-data-sheet_eng.pdf 4. World Health Organization. Obesity and overweight . Fact sheet N°311. 2015 [Cited in 18.01.2015] Available from: http://www.who.int/mediacentre/factsheets/fs311/en/ 5. Population Reference Bureau . World population data sheet 2014 Washington, USA. [Cited in 18.01.2015] Available from: http://www.prb.org/Publications/Datasheets/2014/2014-world-population-data-sheet/population-clock.aspx 6. U.S. Census Bureau. International Data Base 2015. Washington, USA [Cited in 18.01.2015 ] Available from: http

Open access

Mohamed Abdelhaq Abbes and Karima Bereksi-Reguig

References 1. Benjamin EJ, Blaha MJ, Chiuve SE et al. Heart disease and stroke statistics-2017 update: A report from the american heart association. Circulation 135: e146- e603, 2017. 2. Haslam DW, James WP. Obesity. Lancet 366: 1197-209, 2005. 3. Lordan R, Zabetakis I. Invited review: The antiinflammatory properties of dairy lipids. J Dairy Sci 100 :4197-4212, 2017. 4. O’Keefe JH, Gheewala NM, O’Keefe JO. Dietary strategies for improving post-prandial glucose, lipids, inflammation, and

Open access

Gholamreza Pouryaghoub, Ramin Mehrdad and Mohammad Mehraban

. Physiol Pharmacol 20(2016): 90-97, 2016 14. Irfan M, Jabbar A, Haque AS, Awan S, Hussain SF. Pulmonary functions in patients with diabetes mellitus. Lung India 28(2): 89-92, 2011 15. Yeh F, Dixon AE, Marion S et al. Obesity in adults is associated with reduced lung function in metabolic syndrome and diabetes: the Strong Heart Study. Diabetes Care 34(10): 2306-13, 2011 16. Kim CH, Kim HK, Kim EH et al. Association of restrictive ventilatory dysfunction with the development of prediabetes and type 2 diabetes in Koreans. Acta Diabetol 52(2): 357

Open access

Raluca-Iulia Juncar, Mihai Juncar, Florin-Onişor Gligor and Amorin-Remus Popa

. 13. Bornstein MM, Cionca N, Mombelli A. Systemic conditions and treatments as risks for implant therapy. Int J Oral Maxillofac Implants 24(Suppl): 12-27, 2009. 14. Ghiraldini B, Conte A, Casarin RC et al. Influence of glycemic control on peri-implant bone healing: 12-month outcomes of local release of bonerelated factors and implant stabilization in type 2 diabetics. Clin Implant Dent Relat Res Mar 30, 2015. doi: 10.1111/cid.12339. [Epub ahead of print] 15. Courtney MW Jr, Snider TN, Cottrell DA. Dental implant placement in type II

Open access

Monica Vereş, Aurel Babeş and Szidonia Lacziko

-23, 2001. 3. King H. Epidemiology of glucose intolerance and gestational diabetes in women of childbearing age. Diabetes Care 21[Suppl. 2]: B9- B13, 1998. 4. Di Cianni G, Volpe L, Lencioni C et al. Prevalence and risk factors for gestational diabetes assessed by universal screening. Diabetes Res Clin Pract 62: 131- 137, 2003. 5. Kurishita M, Nakashima K, Kozu H. A retrospective study of glucose metabolism in mothers of large babies. Diabetes Care 17:649-52, 1994. 6. Cunningham FG, Leveno KJ, Bloom

Open access

Seyed Mansour Alamshah, Aliasghar Hemmati and Zahra Nazari

References 1. Bentley J, Foster A. Multidisciplinary management of the diabetic foot ulcer. Br J Community Nurs 12: S6, S8, S10 passim, 2007. 2. Jason H, Calvoun, Jon T, Mader. Diabetic foot care. In: Chapman’s Orthopedic Surgery, 3th edition. Michael W Chapman (ed). Lippincott Williams &Wilkins, Philadelphia, pp 3073-76, 2001. 3. Koltuksuz U, Mutus HM, Kutlu R, et al. Effects of caffeic acid phenethyl ester and epidermal growth factor on the development of caustic esophageal stricture in rats. J Pediatr Surg 36

Open access

Marlena Pascu, Ruxandra Miulescu and C. Ionescu-Tîrgoviste

References Alexandru Carmina, Nicolau A. Ceausu I, Guja C , Ionescu Targoviste C. Trends in the Outcome of Dibetic Pregnancies in Bucharest. Acta Diabetologica 28 (2002) Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus: the organizing committee. Diabetes Care 21 (Suppl.2): B161-B167, 1998. O'Sullivan JB, Maham CM. Criteria for oral glucose tolerance test in pregnancy. Diabetes 13: 278

Open access

Marilena Stoian, Victor Stoica and Gabriela Radulian

at preventing worsening of the metabolic syndrome. Int Heart J 49: 193-203, 2008. 11. Kolovou GD, Anagnostopoulou KK, Salpea KD et al. The prevalence of metabolic syndrome in various populations. Am J Med Sci 333: 362-371, 2007. 12. Hu G, Lindstrom J, Jousilahti P et al . The increasing prevalence of metabolic syndrome among Finnish men and women over a decade. J Clin Endocrinol Metab 93: 832-836, 2008. 13. Erem C, Hacihasanoglu A, Deger O et al. Prevalence of metabolic syndrome and associated risk factors among

Open access

Luciana Goguţă, Diana Lungeanu and Anca Jivănescu

R eferences 1. Renard LM, Bocquet V, Vidal-Trecan G et al. Adherence to international follow-up guidelines in type 2 diabetes: a longitudinal cohort study in Luxembourg. PLoS One 8(11):11, 2013. 2. Sandberg GE, Sundberg HE, Fjellstrom CA, et.al. Type 2 diabetes and oral health: a comparison between diabetic and non-diabetic subjects. Diabetes Res Clin Pract 50(1): 27-34, 2000. 3. Yamaga E, Sato Y, Minakuchi S. A structural equation model relating oral condition, denture quality, chewing ability, satisfaction, and oral health

Open access

Adina Mitrea, Maria Mota, Daniela Patru, Amorin Remus Popa, Diana Protasiewicz, Robert Dinu, Cristina Muntean, Raluca Dina, Magda Sandu, Flavia Dinu and Betty Bornagel

Abstract

As the latest data from the International Diabetes Federation (IDF) have shown, diabetes mellitus (DM) prevalence and incidence are continually increasing. Our purposes were to identify the socio-demographical characteristics of the subjects diagnosed with DM prior to this study, to establish the percent they represent of the studied group, to evaluate the metabolic control of the subjects enrolled in the study, as well as to ascertain whether the blood glucose level or the glycated haemoglobin (HbA1c) measurement leads to the detection of a higher percentage of DM newly diagnosed cases. The study conducted in 3 Romanian cities enrolled 4133 subjects (1340 from Craiova, 1224 from Oradea and 1569 from Sibiu). 1413 subjects (34%) reported having been diagnosed with DM prior to our study. Most of the subjects previously diagnosed with DM, 65%, take oral antidiabetic agents (OAA), 13% take insulin and 4% take both OAA and insulin. 20% of the subjects who did not report DM had a blood glucose level ≥126mg/dL and 17% of them had an HbA1c ≥6.5%, leading to a high number of newly diagnosed DM cases, therefore emphasising the importance of the simultaneous determination of these two parameters. The results of this study confirm the increasing prevalence of DM and the necessity of future studies in order to asses DM accurate prevalence in Romania.